Table 2.

Comparison of the incidence of postoperative VTE between the two groups

Outcomes	Aspirin (n = 198)	Rivaroxaban (n = 192)	P‐value
	no.%	no.%
Venous thromboembolism	13(6.6)	11(5.7)	0.83
Pulmonary embolism	1 (0.5)	0 (0)	1.00
Proximal DVT	12 (6.1)	10 (5.2)	0.83
Pulmonary embolism + Proximal DVT	0	1(0.5)	0.49
DVT in the calf	21 (10.6)	19(9.9)	0.87

Note: No lethal pulmonary embolism occurred in both groups.